Delivery Order SPE2DB20D3103-SPE2DB23FM2W7
Award Date 1/27/23
Potential Completion Date 1/30/23
Potential Value $2.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $12,657.86 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, which are used to treat HIV/AIDS. The contract has a ceiling value of $12,657.86 and runs through August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a $1,241.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, a medication commonly used in the treatment of HIV. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,921.83 delivery order is for the supply of emtricitabine-tenofovir 200-300mg tablets, a medication used in the treatment of HIV/AIDS. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,098.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a specialty medication used to treat HIV. The award was made under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,766.47 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300mg tablets, a critical medication used for the prevention and treatment of HIV. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,302.29 delivery order is for the supply of Emtricitabine-Tenofv 200-300mg tablets, which are used to treat HIV/AIDS and related conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM2N4, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,181.03, is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a medication used for the treatment of HIV/AIDS. The contract is a delivery order with a firm fixed price and an ultimate completion date of January 12, 2024....
- This federal contract award is for the delivery of emtricitabine-tenofovir 200-300 mg tablets, a pharmaceutical product used to treat HIV. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,523.63 and a completion date of March 10, 2022. It was awarded on March 9, 2022, and was not set aside for any specific business...
- This is a $5,490.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...